Anti-tumor potential of retinoic acid: Stimulation of immune mediated effectors
โ Scribed by Paul Q. Patek; John Leslie Collins; Ganesa Yogeeswaran; Gunther Dennert
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- French
- Weight
- 426 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Data are presented on the effects of retinoic acid (RA) treatment on the in vivo growth of tumors in two mouse strains. Inhibition of tumor growth as a result of systemic RA injection was observed in three out of seven tumor models. Using adult thymectomized, lethally irradiated and fetal liver (A ร TFL) reconstituted mice, we found that inhibition of tumor growth is not due to direct toxic effects of RA but rather appears to be the result of stimulation of thymusโdependent immuneโmediated effectors able to suppress tumor growth. Results suggest that only strongly immunogenic tumors are sensitive to in vivo retinoid inhibition.
๐ SIMILAR VOLUMES
## Abstract A patient with melanoma was found to have lymphocytes highly cytotoxic for autogenous tumor cells but not for fibroblasts. Autogenous serum did not block the cytotoxicity. He then received an injection of BCG into a small tumor nodule. Three weeks later, in association with accelerated
## Abstract In this study we investigated the relationship between binding of antiโtumor antibodies by polyomaโvirusโinduced SEYFโa tumor cells and the expression of immuneโcomplex receptors on these cells. It was shown that in vivo propagated cells became progressively coated with IgG. The increas
Studies in vivo using inhibitors of eicosanoid synthesis suggested that prostaglandins may play a role in mediating tumor promotion in liver by agents such as phenobarbital (PB). However, it is not clear whether any stimulation of arachidonic acid metabolism/prostaglandin formation results directly
The NKG2D receptor is expressed by human NK, gammadelta T and alpha/beta T lymphocytes and its engagement results in the stimulation of effector cells. We evaluated the role of NKG2D receptor in anti-colorectal cancer (CRC) immune response. The cell surface expression of stress-inducible NKG2D ligan